Patients’ Portal: New Languages added As part of our ongoing commitment to ensuring our patients are well informed about their role in the clinical trials process, Cromos Pharma has translated its patient portal into multiple new languages. In addition to currently available languages that include English, Czech, Georgian, Hungarian, Polish, Ukrainian, Russian, we have added information in Romanian, Slovak, Bulgarian, Türkiyesh,
Cromos Pharma Committed to Patient Centricity in Clinical Trials Over the last few years, patient centricity has moved from buzzword to an imperative. Sponsors are now increasingly willing to offer a patient centric approach to studies. However, there remains some confusion over what this means and how to implement it. In this article Cromos Pharma looks at some of the strategies that can be
An Unseen Cost of the Ukraine War Cromos Pharma’s CEO Vlad Bogin was interviewed by Spotlight on America as part of its investigative report on the situation with clinical trials in Ukraine. Not long-ago Ukraine was a highly attractive location for clinical trials offering numerous distinct advantages for international sponsors including: Excellent recruitment potential due to its large population of modern
